324 related articles for article (PubMed ID: 17058128)
1. Clinicopathologic prognostic factors in myxoid liposarcoma: a retrospective study of 49 patients with long-term follow-up.
ten Heuvel SE; Hoekstra HJ; van Ginkel RJ; Bastiaannet E; Suurmeijer AJ
Ann Surg Oncol; 2007 Jan; 14(1):222-9. PubMed ID: 17058128
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.
Antonescu CR; Tschernyavsky SJ; Decuseara R; Leung DH; Woodruff JM; Brennan MF; Bridge JA; Neff JR; Goldblum JR; Ladanyi M
Clin Cancer Res; 2001 Dec; 7(12):3977-87. PubMed ID: 11751490
[TBL] [Abstract][Full Text] [Related]
3. Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.
Fiore M; Grosso F; Lo Vullo S; Pennacchioli E; Stacchiotti S; Ferrari A; Collini P; Lozza L; Mariani L; Casali PG; Gronchi A
Cancer; 2007 Jun; 109(12):2522-31. PubMed ID: 17510918
[TBL] [Abstract][Full Text] [Related]
4. Myxoid\round cell liposarcoma (MRCLS) revisited: an analysis of 418 primarily managed cases.
Moreau LC; Turcotte R; Ferguson P; Wunder J; Clarkson P; Masri B; Isler M; Dion N; Werier J; Ghert M; Deheshi B;
Ann Surg Oncol; 2012 Apr; 19(4):1081-8. PubMed ID: 22052112
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors of myxofibrosarcomas: implications of margin status, tumor necrosis, and mitotic rate on survival.
Lin CN; Chou SC; Li CF; Tsai KB; Chen WC; Hsiung CY; Yen CF; Huang HY
J Surg Oncol; 2006 Mar; 93(4):294-303. PubMed ID: 16496357
[TBL] [Abstract][Full Text] [Related]
7. Soft tissue sarcoma. Epidemiology and prognosis in 508 patients.
Gustafson P
Acta Orthop Scand Suppl; 1994 Jun; 259():1-31. PubMed ID: 8042499
[TBL] [Abstract][Full Text] [Related]
8. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.
Singer S; Antonescu CR; Riedel E; Brennan MF
Ann Surg; 2003 Sep; 238(3):358-70; discussion 370-1. PubMed ID: 14501502
[TBL] [Abstract][Full Text] [Related]
9. The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases.
Kilpatrick SE; Doyon J; Choong PF; Sim FH; Nascimento AG
Cancer; 1996 Apr; 77(8):1450-8. PubMed ID: 8608528
[TBL] [Abstract][Full Text] [Related]
10. Skeletal metastases in myxoid liposarcoma: an unusual pattern of distant spread.
Schwab JH; Boland P; Guo T; Brennan MF; Singer S; Healey JH; Antonescu CR
Ann Surg Oncol; 2007 Apr; 14(4):1507-14. PubMed ID: 17252290
[TBL] [Abstract][Full Text] [Related]
11. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
12. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.
Oda Y; Yamamoto H; Takahira T; Kobayashi C; Kawaguchi K; Tateishi N; Nozuka Y; Tamiya S; Tanaka K; Matsuda S; Yokoyama R; Iwamoto Y; Tsuneyoshi M
J Pathol; 2005 Dec; 207(4):410-21. PubMed ID: 16177957
[TBL] [Abstract][Full Text] [Related]
13. Time dependence of prognostic factors for patients with soft tissue sarcoma: a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas.
Engellau J; Anderson H; Rydholm A; Bauer HC; Hall KS; Gustafson P; Akerman M; Meis-Kindblom J; Alvegård TA; Nilbert M;
Cancer; 2004 May; 100(10):2233-9. PubMed ID: 15139069
[TBL] [Abstract][Full Text] [Related]
14. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma.
Pautier P; Genestie C; Rey A; Morice P; Roche B; Lhommé C; Haie-Meder C; Duvillard P
Cancer; 2000 Mar; 88(6):1425-31. PubMed ID: 10717626
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
16. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
17. Spinal metastases from myxoid liposarcoma warrant screening with magnetic resonance imaging.
Schwab JH; Boland PJ; Antonescu C; Bilsky MH; Healey JH
Cancer; 2007 Oct; 110(8):1815-22. PubMed ID: 17724681
[TBL] [Abstract][Full Text] [Related]
18. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M
J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
[TBL] [Abstract][Full Text] [Related]
19. Clinical course of nonvisceral soft tissue leiomyosarcoma in 225 patients from the Scandinavian Sarcoma Group.
Svarvar C; Böhling T; Berlin O; Gustafson P; Follerås G; Bjerkehagen B; Domanski HA; Sundby Hall K; Tukiainen E; Blomqvist C;
Cancer; 2007 Jan; 109(2):282-91. PubMed ID: 17154171
[TBL] [Abstract][Full Text] [Related]
20. Tumor volume as a prognostic factor for sarcomatosis.
Bilimoria MM; Holtz DJ; Mirza NQ; Feig BW; Pisters PW; Patel S; Pollock RE; Benjamin RS; Papadopoulos NE; Plager C; Murphy A; Griffin JR; Burgess MA; Hunt KK
Cancer; 2002 May; 94(9):2441-6. PubMed ID: 12015769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
